Wellington Management Group LLP Madrigal Pharmaceuticals, Inc. Transaction History

Wellington Management Group LLP

$557 Billion
Q3 2024

A detailed history of Wellington Management Group LLP transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 9,031 shares of MDGL stock, worth $3.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,031

Holding current value

$3.06 Million

% of portfolio

0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$212.22 - $292.96 $1.92 Million - $2.65 Million	9,031 New	9,031 $1.92 Million
Q4 2023 Feb 12, 2024	BUY	$120.4 - $237.13 $629,330 - $1.24 Million	5,227 New	5,227 $1.21 Million
Q1 2023 May 12, 2023	SELL	$231.06 - $307.08 $3.7 Million - $4.92 Million	-16,019 Reduced 50.33%	15,811 $3.83 Million
Q4 2022 Feb 13, 2023	BUY	$58.39 - $296.54 $446,917 - $2.27 Million	7,654 Added 31.66%	31,830 $9.24 Million
Q3 2022 Nov 14, 2022	SELL	$60.57 - $79.51 $14,718 - $19,320	-243 Reduced 1.0%	24,176 $1.57 Million
Q2 2022 Aug 15, 2022	SELL	$58.04 - $100.2 $50.9 Million - $87.9 Million	-876,871 Reduced 97.29%	24,419 $1.75 Million
Q1 2022 May 16, 2022	SELL	$55.89 - $101.89 $23.4 Million - $42.7 Million	-419,505 Reduced 31.76%	901,290 $88.4 Million
Q4 2021 Feb 11, 2022	BUY	$72.34 - $95.09 $21.9 Million - $28.8 Million	302,777 Added 29.74%	1,320,795 $112 Million
Q3 2021 Nov 15, 2021	BUY	$78.35 - $105.02 $11.8 Million - $15.8 Million	150,252 Added 17.31%	1,018,018 $81.2 Million
Q2 2021 Aug 16, 2021	BUY	$97.2 - $137.59 $4.95 Million - $7.01 Million	50,932 Added 6.24%	867,766 $84.5 Million
Q1 2021 May 17, 2021	SELL	$108.54 - $125.2 $10.8 Million - $12.4 Million	-99,058 Reduced 10.82%	816,834 $95.5 Million
Q4 2020 Feb 12, 2021	BUY	$110.06 - $133.7 $13.9 Million - $16.8 Million	125,989 Added 15.95%	915,892 $102 Million
Q3 2020 Nov 16, 2020	SELL	$99.78 - $124.21 $4.9 Million - $6.1 Million	-49,078 Reduced 5.85%	789,903 $93.8 Million
Q2 2020 Aug 14, 2020	SELL	$60.13 - $125.71 $2.1 Million - $4.39 Million	-34,934 Reduced 4.0%	838,981 $95 Million
Q1 2020 May 14, 2020	SELL	$66.76 - $93.49 $5.56 Million - $7.78 Million	-83,231 Reduced 8.7%	873,915 $58.3 Million
Q4 2019 Feb 11, 2020	BUY	$84.28 - $118.5 $80.7 Million - $113 Million	957,146 New	957,146 $87.2 Million

Others Institutions Holding MDGL

# of Institutions

296

Shares Held

22M

Call Options Held

819K

Put Options Held

640K

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.8B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Madrigal Pharmaceuticals, Inc. Transaction History